Lineage Cell Therapeutics Inc (LCTX) has fallen Thursday morning, with the stock decreasing -2.14% in pre-market trading to 1.37. LCTX's short-term technical score of 59 indicates that the stock has traded more bullishly over the last month than 59% of stocks on the market. In the Biotechnology industry, which ranks 104 out of 146 industries, LCTX ranks higher than 71% of stocks. Lineage Cell Therapeutics Inc has risen 34.62% over the past month, closing at $1.04 on February 29. During this period of time, the stock fell as low as $1.04 and as high as $1.45. LCTX has an average analyst recommendation of Strong Buy. The company has an average price target of $4.67.
LCTX has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on LCTX!